Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma Research Letter


Authors: Santoro, A.; Moskowitz, A. J.; Ferrari, S.; Carlo-Stella, C.; Lisano, J.; Francis, S.; Wen, R. C.; Akyol, A.; Savage, K. J.
Title: Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
Keywords: hodgkin lymphoma; expression; reveals; b-cell lymphoma
Journal Title: Blood
Volume: 141
Issue: 22
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-06-01
Start Page: 2780
End Page: 2783
Language: English
ACCESSION: WOS:001016065500001
DOI: 10.1182/blood.2022017951
PROVIDER: wos
PUBMED: 36898084
Notes: Letter -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alison Moskowitz
    339 Moskowitz